Venture Capital & Emerging Companies
Viewpoints
Filter by:
With You Every Step of the Way: Paving Your Pathway to the Public Markets
July 15, 2024 | Alert
Mintz regularly represent the most innovative companies from inception through exit with the experience and expertise necessary to guide YOU through a successful IPO process and beyond.
Crossing Borders: Key Considerations for International VC Investments
July 9, 2024 | Advisory | By Kaoru C. Suzuki
This article provides information for international angel investors and venture funds looking to invest in start-ups in the United States, including on investment frameworks like how terms are handled, regulatory considerations, and US tax implications.
Acing Your First Start-up Board Meeting: Board Deck Tips
July 2, 2024 | Alert | By Kaoru C. Suzuki
This article provides a detailed overview of how company founders can create an effective board deck to prepare for a meeting with investor directors.
MintzTech Connect Industry News: Spotlight on Radicle Science
June 13, 2024 | Article | By Jeremy Glaser, Sophia Fein
Read about Radicle Science, a B-corp transforming the supplement industry’s approach to clinical trials and efficacy validation through virtual trials that greatly expand the scale and diversity of trial participants.
MintzTech Connect Event Highlight: The Sustainable Media Center
June 13, 2024 | Article
MintzTech Connect: All Things Technology — June 2024
June 13, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers the FTC’s controversial final rule banning most post-employment non-competes, qualified small business stock issues affecting the conversion of an LLC into a corporation, clinical trial innovator Radicle Science, and an event co-sponsored by Mintz and the Sustainable Media Center, which focused on the impact of social media on today’s youth.
Preparing a VC-Backed Company for an Exit Event
April 22, 2024 | Alert | By Stephen M. Callegari, Stefan Jović
This alert provides an overview of critical steps companies can take to ensure that an M&A exit event runs smoothly, including ensuring internal agreement on the sale, establishing an M&A team, attending to legal housekeeping matters, and carefully reviewing term sheets received from potential bidders.
Important Updates to the New York LLC Transparency Act
April 15, 2024 | Advisory | By Daniel DeWolf, Sophia Fein
The New York LLC Transparency Act, which takes effect on January 1, 2026, will require limited liability companies formed or authorized to do business in New York to make certain disclosures aimed at preventing the use of anonymous LLCs for illicit activities.
From the Edge - MintzEdge Entrepreneur Perspective: Mintz Awards Winners Share Strategies for Success
April 1, 2024 | Podcast | By Jason S. Miller
Join Mintz Corporate and Securities Associate, Jason Miller, in a conversation with Margaret Yu, founder and CEO of Reliacare, and Andrew Gladue, founder and CEO of Plethys.
MintzTech Connect: All Things Technology — March 2024
March 20, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers Corporate Transparency Act compliance requirements, considerations for companies undertaking Section 409A valuations, and Mintz’s year in review of laws impacting employee non-competition, non-solicitation, and non-disclosure agreements.
Essential Annual Actions for Start-up Boards
March 18, 2024 | Alert | By Kaoru C. Suzuki
As a start-up begins to approach its fiscal year-end, company founders need to be mindful of key annual action items for boards, such as the budget, executive compensation, and other administrative actions.
Compliance with the New York LLC Transparency Act Necessary for Many Mintz Clients
March 12, 2024 | Alert | By Daniel DeWolf, Sophia Fein
The New York LLC Transparency Act, which takes effect on December 21, 2024, will require limited liability companies formed or authorized to do business in New York to make certain disclosures aimed at preventing the use of anonymous LLCs for illicit activities.
Client Corner: Meet CEO and COO of Suono Bio, Scott Kellogg & Skip Farinha
March 1, 2024 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh speaks to Suono Bio’s CEO Scott Kellogg and COO Skip Farinha. Scott and Skip discuss the importance of active listening in managing a team, strategies for navigating the medical device approval process in the US, key factors to consider when selecting investors, and insights on managing unforeseen challenges.
Client Corner: Meet Co-founder & CEO of Axoft, Paul Le Floch
February 16, 2024 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh speaks to Paul Le Floch, Co-founder & CEO of Axoft. Paul discusses his journey from growing up in France to becoming a founder and the CEO of a neurotechnology startup. He provides insight into forming Axoft and navigating the fundraising process and offers advice to individuals starting new ventures.
Mintz Venture Watch — Volume 6: A Report on Deal Trends from 2023
February 6, 2024 | Article | By Daniel DeWolf, Samuel Asher Effron, Jeremy Glaser
This edition of Mintz Venture Watch reports on the firm’s VC transaction activity in 2023. Mintz represented issuers and investors in the technology, energy, life sciences, and other sectors in more than 130 transactions valued at over $2.6 billion.
New for 2024: Compliance with the Corporate Transparency Act Necessary for Many Mintz Clients
February 1, 2024 | Alert | By Will Perkins, Steve Ganis, Daniel Gaquin, Daniel Guggenheim, David Adams
Reporting requirements under the Corporate Transparency Act (CTA) are in effect beginning January 1, 2024. Under the CTA, many US entities will be required to provide the personal information of their beneficial owners to the Financial Crimes Enforcement Network (FinCEN), a division of the US Treasury Department.
Section 409A Valuations: Mastering the Art and Science in a Volatile Venture Market
January 23, 2024 | Article | By Dinesh Melwani, Roman M. Gorokhov
In this article, we explore the intricacies of 409A valuations, focusing on their importance, timing, and methodologies, and offer strategies for challenging valuations — assuming reliance on third-party assessments.
Client Corner: Gio Traverso’s Journey Starting Biotech Companies
January 12, 2024 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh speaks to Gio Traverso, MIT professor, founder of several biotech companies, and a physician. Gio discusses his experience starting six different companies with Josh, comprising both for-profit and nonprofit entities. He reflects upon the process of deciding whether to start a business using a nonprofit or a for-profit structure, bringing together a strong team, evaluating potential investors, and licensing intellectual property from a university.
MintzTech Connect: All Things Technology — December 2023
December 15, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers a Globe and Mail piece on Mintz’s continued expansion in Toronto, Biden’s executive order on artificial intelligence, Forbes magazine’s recognition of Moolah Kicks founder Natalie White’s inclusion on its “30 Under 30” list, and our Client Corner podcast featuring a conversation with NextGen Jane Co-founder & CEO Ridhi Tariyal.
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology